Chronic News and Research

RSS

Report on ageing world inspires employers to expand and shift their strategic thinking, says Chairman of Mercer

The World Economic Forum has just published Transforming Pensions and Healthcare in a Rapidly Ageing World: Opportunities and Collaboration Strategies with the support of Mercer and the OECD (Organisation for Economic Cooperation and Development). The report and a related Mercer Perspective can be downloaded at www.mercer.com/WEF.

3 Sep 2009

SYNTAX clinical trial results announced

Boston Scientific Corporation (NYSE: BSX) today announced two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the TAXUS((R)) Express((R)) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.

3 Sep 2009

Fashion show to help raise public awareness of psoriasis

Today, Tim Gunn, television host and fashion consultant ("Project Runway," "Tim Gunn's Guide to Style") and chief creative officer of Liz Claiborne, Inc., is hosting the Addressing Psoriasis(TM) Fashion Show, sponsored by Amgen and Wyeth, in New York City.

3 Sep 2009

New electronic medical device for treating leg pain

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has released a new way to deliver the impulses of the ReBuilder for pain.

3 Sep 2009

Gene-Eden antiviral supplement may offer protection against swine flu

Everyone is looking for ways to protect themselves against the swine flu virus. Let me tell you about my personal encounter with the virus. About three months ago, I read an article on Dr. Hanan Polansky's book, where he describes his discovery of the relationship between chronic viruses and chronic disease. After I read the article, I started taking Gene-Eden, a broad range antiviral supplement, to reduce the number of chronic viruses in my body.

3 Sep 2009

Aerocrine’s NIOX MINO technology approved in Canada for treating asthma

Aerocrine AB (STO:AEROB) today announced that Health Canada’s Therapeutic Products Directorate has approved Aerocrine’s NIOX MINO® technology for use in treating asthma. Canada’s National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.

3 Sep 2009

Brain profiling tool to detect at-risk combat soldiers

According to a recent Washington Post study, approximately 20% of U.S. soldiers returning from Iraq and Afghanistan are psychologically damaged. Among them are a substantial number with post-traumatic stress disorder (PTSD), and the high rate of suicide among PTSD sufferers has become unacceptable to Army commanders and the soldiers' families.

3 Sep 2009

New online interactive quiz to gauge risk for cavities

Your risk for cavities can be gauged in minutes, thanks to a new interactive quiz launched today by a group of Delta Dental companies.

3 Sep 2009

m.pulse system for MCP therapy installed in ten hospitals

Cardiola AG announced today that it has placed its patented m.pulse system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval. MCP was previously only available in a clinical setting. Now, m.pulse is the world’s first and only device enabling CAD patients to receive MCP therapy at home.

3 Sep 2009

Sepracor to be acquired by Dainippon Sumitomo Pharma for $2.6 billion

Dainippon Sumitomo Pharma Co., Ltd. (“DSP”, TSE: 4506) and Sepracor Inc. (“Sepracor”, Nasdaq: SEPR) today announced that they have entered into a definitive agreement pursuant to which DSP will acquire Sepracor for approximately $2.6 billion through a cash tender offer of $23.00 per share, followed by a merger to acquire all remaining outstanding Sepracor shares at the same price paid in the tender offer.

3 Sep 2009

CIGNA partners with MCNT to launch a medical home type program in Texas

CIGNA (NYSE:CI) and Medical Clinic of North Texas (MCNT) are preparing to launch a pilot program that incorporates components of the medical home model based on a comprehensive, accountable and collaborative approach they believe will lead to improved patient access, better continuity and coordination of care, improved quality of care for patients, and lower medical costs.

2 Sep 2009

SynerMed's announces a 35 percent growth in membership since the beginning of the first quarter of 2009

SynerMed, Inc. today announced a 35 percent growth in membership since the beginning of the first quarter of 2009. Representing 550,000 beneficiaries through its clients, SynerMed is the largest Medicaid managed service organization (MSO) in the country.

2 Sep 2009

Wallet-sized cards offer athletes tips for detecting and monitoring concussions

In response to a rising number of concussions and recent research which shows young athletes with repeated brain injuries are at great risk for future neurological problems, the Illinois Athletic Trainers Association (IATA) and the Chicago Institute of Neurosurgery and Neuroresearch (CINN) are offering a wallet-sized card with tips for detecting and monitoring concussions. The complimentary card is an educational tool for parents, coaches and others who work with young athletes to help them identify signs of a concussion.

2 Sep 2009

Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).

2 Sep 2009

BRNI announces agreement to advance research on brain and neurological disorders

The Blanchette Rockefeller Neurosciences Institute (BRNI) announced today an agreement with a group of neurological specialists (Brain Injury Group) to examine possible confluences of the Group's work with brain injuries, head trauma, and strokes and BRNI's research.

2 Sep 2009

SUPERVALU PHARMACIES available to administer flu shots

With an eye on convenience, cost and consumer education, SUPERVALU PHARMACIES this year has expanded its traditional flu shot offering to help ease some of the anxieties the upcoming flu season may bring.

2 Sep 2009

Lupus Foundation of America to educate people with lupus on clinical trial participation

It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.

2 Sep 2009

Public-private collaboration to fund research on health, diet and green technology

A total of £7M funding has been announced today by two public-private collaborations led by the Biotechnology and Biological Sciences Research Council (BBSRC).

2 Sep 2009

LUNA surgical procedure did not alleviate chronic pelvic pain in women

A surgical procedure known as LUNA (laparoscopic uterosacral nerve ablation) did not result in improvements in chronic pelvic pain, painful menstruation, painful sexual intercourse or quality of life when compared with laparoscopic surgery that does not interrupt pelvic nerve connections, according to a study in the September 2 issue of JAMA.

2 Sep 2009

CardioWest Total Artificial Heart recipient going strong for more than 10 months

Over the last five years, Jim Hennigan has had four different hearts beating in his chest… the heart he was born with, two donor hearts and a Total Artificial Heart.

2 Sep 2009